A DNA-based blood test is changing the future of cancer detection by spotting more than 50 types of the disease before symptoms appear.
Known as Galleri, the test scans the bloodstream for tiny fragments of tumour DNA shed by cancer cells, allowing doctors to identify early signs of cancer, pinpo
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Royal Ibeh
Royal Ibeh is a senior journalist with years of experience reporting on Nigeria’s technology and health sectors. She currently covers the Technology and Health beats for BusinessDay newspaper, where she writes in-depth stories on digital innovation, telecom infrastructure, healthcare systems, and public health policies.
